LOADING
Comparing AbbVie Inc (ABBV) and PepsiCo Inc (PEP) across the Health Care and Consumer Staples sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | PEP |
|---|---|---|
| Price | $257.12 | $136.32 |
| Change Today | +0.83% | -0.24% |
| Market Cap | $454.4B | $186.2B |
| P/E Ratio | 72.0 | 17.9 |
| Forward P/E | 15.8 | 15.1 |
| PEG Ratio | 0.52 | 1.40 |
| EPS | $3.57 | $7.61 |
| Revenue Growth (YoY) | 10.2% | 6.4% |
| Profit Margin | 9.8% | 10.8% |
| Return on Equity | 62.3% | 51.5% |
| Dividend Yield | 2.68% | 4.21% |
| Beta | 0.28 | 0.36 |
| 52-Week High | $267.47 | $166.41 |
| 52-Week Low | $189.40 | $131.99 |
| Volume | 4.3M | 8.8M |
AbbVie Inc is the larger company by market capitalization. PepsiCo Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. PepsiCo Inc offers a higher dividend yield for income investors. PepsiCo Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.